ASML Orders Miss Forecasts as Chip Makers Await Demand Recovery — 2nd Update
By Mauro Orru
ASML Holding posted orders below analysts' expectations for the first quarter as chip makers wait for demand to recover before securing key production equipment for the coming months and years.
The Dutch company, which makes equipment for chip makers, said orders slipped to 3.61 billion euros ($3.83 billion) in the three months to the end of March from EUR3.75 billion a year earlier. Analysts had forecast orders of nearly EUR5.10 billion, according to consensus estimates by Visible Alpha.
ASML's lackluster orders show that its customers, major chip makers like Taiwan Semiconductor Manufacturing Co., Intel and Samsung Electronics, are for now shying away from buying up machinery and other semiconductor-making equipment in anticipation of better demand.
TSMC, the world's largest contract chip maker, reported a rare 8.7% contraction in revenue last year. Chip makers have been grappling with an inventory glut in recent months as manufacturers of smartphones, computers and other personal-electronic devices held off ordering more chips that they had stockpiled in recent years.
Now, those companies are digesting their inventories and chip makers are seeing the first signs that demand for semiconductors will recover this year. TSMC expects revenue this year to grow more than 20%.
Meanwhile, the Biden administration is handing out billions of dollars in subsidies to companies, such as TSMC, Intel and Samsung, willing to invest in chip-making facilities in the U.S. in a move aimed at reviving hardware manufacturing in the country.
ASML shares have been on the rise in recent months, amid expectations that it would benefit from a recovering semiconductor market. The stock is up about 34% since the year began at EUR913.40. A year ago, shares traded at roughly EUR580.00.
Chief Executive Officer Peter Wennink said 2024 would be a transition year, expecting a stronger second half in line with the industry's recovery from the downturn. For the year, sales should be similar to the EUR27.56 billion that ASML reported for 2023.
In the first quarter, however, ASML's sales fell to EUR5.29 billion from EUR6.75 billion, missing analysts' forecasts. For the current quarter, the group expects sales between EUR5.7 billion and EUR6.2 billion.
Net profit declined to EUR1.22 billion from nearly EUR1.96 billion, but it still exceeded analysts' EUR1.09 billion forecast.
Gross profit--a closely watched metric for companies operating in the semiconductor industry--came in at EUR2.70 billion, generating a 51% margin that beat consensus and company guidance. For the current quarter, ASML is forecasting a gross margin between 50% and 51%.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
April 17, 2024 02:27 ET (06:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track